The CBI-R detects early behavioural impairment in genetic frontotemporal dementia.


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
05 2022
Historique:
revised: 23 02 2022
received: 17 01 2022
accepted: 25 02 2022
entrez: 11 8 2022
pubmed: 12 8 2022
medline: 13 8 2022
Statut: ppublish

Résumé

Behavioural dysfunction is a key feature of genetic frontotemporal dementia (FTD) but validated clinical scales measuring behaviour are lacking at present. We assessed behaviour using the revised version of the Cambridge Behavioural Inventory (CBI-R) in 733 participants from the Genetic FTD Initiative study: 466 mutation carriers (195 C9orf72, 76 MAPT, 195 GRN) and 267 non-mutation carriers (controls). All mutation carriers were stratified according to their global CDR plus NACC FTLD score into three groups: asymptomatic (CDR = 0), prodromal (CDR = 0.5) and symptomatic (CDR = 1+). Mixed-effects models adjusted for age, education, sex and family clustering were used to compare between the groups. Neuroanatomical correlates of the individual domains were assessed within each genetic group. CBI-R total scores were significantly higher in all CDR 1+ mutation carrier groups compared with controls [C9orf72 mean 70.5 (standard deviation 27.8), GRN 56.2 (33.5), MAPT 62.1 (36.9)] as well as their respective CDR 0.5 groups [C9orf72 13.5 (14.4), GRN 13.3 (13.5), MAPT 9.4 (10.4)] and CDR 0 groups [C9orf72 6.0 (7.9), GRN 3.6 (6.0), MAPT 8.5 (13.3)]. The C9orf72 and GRN 0.5 groups scored significantly higher than the controls. The greatest impairment was seen in the Motivation domain for the C9orf72 and GRN symptomatic groups, whilst in the symptomatic MAPTgroup, the highest-scoring domains were Stereotypic and Motor Behaviours and Memory and Orientation. Neural correlates of each CBI-R domain largely overlapped across the different mutation carrier groups. The CBI-R detects early behavioural change in genetic FTD, suggesting that it could be a useful measure within future clinical trials.

Identifiants

pubmed: 35950369
doi: 10.1002/acn3.51544
pmc: PMC9082390
doi:

Substances chimiques

C9orf72 Protein 0
Progranulins 0
tau Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

644-658

Subventions

Organisme : Medical Research Council
ID : MR/T046015/1
Pays : United Kingdom
Organisme : Department of Health
ID : BRC149/NS/MH
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008525/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M023664/1
Pays : United Kingdom

Investigateurs

Sónia Afonso (S)
Maria Rosario Almeida (MR)
Sarah Anderl-Straub (S)
Christin Andersson (C)
Anna Antonell (A)
Silvana Archetti (S)
Andrea Arighi (A)
Mircea Balasa (M)
Myriam Barandiaran (M)
Nuria Bargalló (N)
Robart Bartha (R)
Benjamin Bender (B)
Alberto Benussi (A)
Maxime Bertoux (M)
Anne Bertrand (A)
Valentina Bessi (V)
Sandra Black (S)
Martina Bocchetta (M)
Sergi Borrego-Ecija (S)
Jose Bras (J)
Alexis Brice (A)
Rose Bruffaerts (R)
Agnès Camuzat (A)
Marta Cañada (M)
Valentina Cantoni (V)
Paola Caroppo (P)
David Cash (D)
Miguel Castelo-Branco (M)
Olivier Colliot (O)
Thomas Cope (T)
Vincent Deramecourt (V)
María de Arriba (M)
Giuseppe Di Fede (G)
Alina Díez (A)
Diana Duro (D)
Chiara Fenoglio (C)
Camilla Ferrari (C)
Catarina B Ferreira (CB)
Nick Fox (N)
Morris Freedman (M)
Giorgio Fumagalli (G)
Aurélie Funkiewiez (A)
Alazne Gabilondo (A)
Roberto Gasparotti (R)
Serge Gauthier (S)
Stefano Gazzina (S)
Giorgio Giaccone (G)
Ana Gorostidi (A)
Caroline Greaves (C)
Rita Guerreiro (R)
Carolin Heller (C)
Tobias Hoegen (T)
Begoña Indakoetxea (B)
Vesna Jelic (V)
Hans-Otto Karnath (HO)
Ron Keren (R)
Gregory Kuchcinski (G)
Tobias Langheinrich (T)
Thibaud Lebouvier (T)
Maria João Leitão (MJ)
Albert Lladó (A)
Gemma Lombardi (G)
Sandra Loosli (S)
Carolina Maruta (C)
Simon Mead (S)
Lieke Meeter (L)
Gabriel Miltenberger (G)
Rick van Minkelen (R)
Sara Mitchell (S)
Katrina Moore (K)
Benedetta Nacmias (B)
Annabel Nelson (A)
Linn Öijerstedt (L)
Jaume Olives (J)
Sebastien Ourselin (S)
Alessandro Padovani (A)
Jessica Panman (J)
Janne M Papma (JM)
Yolande Pijnenburg (Y)
Cristina Polito (C)
Enrico Premi (E)
Sara Prioni (S)
Catharina Prix (C)
Rosa Rademakers (R)
Veronica Redaelli (V)
Daisy Rinaldi (D)
Tim Rittman (T)
Ekaterina Rogaeva (E)
Adeline Rollin (A)
Pedro Rosa-Neto (P)
Giacomina Rossi (G)
Martin Rossor (M)
Beatriz Santiago (B)
Dario Saracino (D)
Sabrina Sayah (S)
Elio Scarpini (E)
Sonja Schönecker (S)
Harro Seelaar (H)
Elisa Semler (E)
Rachelle Shafei (R)
Christen Shoesmith (C)
Imogen Swift (I)
Miguel Tábuas-Pereira (M)
Mikel Tainta (M)
Ricardo Taipa (R)
David Tang-Wai (D)
David L Thomas (DL)
Paul Thompson (P)
Hakan Thonberg (H)
Carolyn Timberlake (C)
Pietro Tiraboschi (P)
Emily Todd (E)
Philip Van Damme (P)
Mathieu Vandenbulcke (M)
Michele Veldsman (M)
Jorge Villanua (J)
Jason Warren (J)
Carlo Wilke (C)
Elisabeth Wlasich (E)
Henrik Zetterberg (H)
Miren Zulaica (M)

Informations de copyright

© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Alzheimers Dement. 2020 Jan;16(1):106-117
pubmed: 31914218
Cortex. 2019 Dec;121:443-453
pubmed: 31715541
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neurology. 2016 Jul 26;87(4):384-91
pubmed: 27358337
J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):162-8
pubmed: 15654025
J Neurol. 2001 Nov;248(11):965-70
pubmed: 11757960
Neurology. 2014 Jul 8;83(2):e19-26
pubmed: 25002573
Brain. 2012 Mar;135(Pt 3):736-50
pubmed: 22366791
Psychogeriatrics. 2019 Jan;19(1):32-37
pubmed: 30073726
Alzheimers Dement (Amst). 2021 May 13;13(1):e12185
pubmed: 34027016
Neurobiol Aging. 2012 Oct;33(10):2506-20
pubmed: 22130207
Neurology. 2011 Aug 30;77(9):866-74
pubmed: 21849646
Neurodegener Dis. 2004;1(4-5):225-30
pubmed: 16908994
Neuroimage Clin. 2016 Dec 02;13:439-445
pubmed: 28116236
Neuroimage. 2015 Jan 1;104:366-72
pubmed: 25255942
Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
Neurology. 2008 Sep 2;71(10):736-42
pubmed: 18765649
J Neurochem. 2016 Aug;138 Suppl 1:6-31
pubmed: 27144467
Rejuvenation Res. 2008 Jun;11(3):585-95
pubmed: 18593276
Brain. 2008 Mar;131(Pt 3):706-20
pubmed: 18234697
Neurology. 2013 Feb 26;80(9):814-23
pubmed: 23390180
Nat Clin Pract Neurol. 2008 Aug;4(8):455-60
pubmed: 18648346
Neurology. 2007 Oct 2;69(14):1424-33
pubmed: 17909155
Nature. 1998 Jun 18;393(6686):702-5
pubmed: 9641683
Neurology. 2009 Nov 3;73(18):1451-6
pubmed: 19884572
Lancet Neurol. 2015 Mar;14(3):253-62
pubmed: 25662776
Nature. 2006 Aug 24;442(7105):920-4
pubmed: 16862115
J Neurol Sci. 2020 Sep 15;416:117007
pubmed: 32623141
J Neurol. 2018 Jun;265(6):1381-1392
pubmed: 29627938
Dement Neuropsychol. 2008 Apr-Jun;2(2):102-107
pubmed: 29213551
JAMA Netw Open. 2021 Jan 4;4(1):e2030194
pubmed: 33404617
Dement Neuropsychol. 2013 Jan-Mar;7(1):75-82
pubmed: 29213823
IEEE Trans Med Imaging. 2015 Sep;34(9):1976-88
pubmed: 25879909
Int J Geriatr Psychiatry. 2017 Sep;32(9):977-982
pubmed: 27464599
Amyotroph Lateral Scler. 2011 Jan;12(1):45-51
pubmed: 20849323
Neurosci Biobehav Rev. 2015 Jul;54:29-37
pubmed: 25862940
Neurology. 2005 Apr 26;64(8):1384-90
pubmed: 15851728

Auteurs

Annabel Nelson (A)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Lucy L Russell (LL)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Georgia Peakman (G)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Rhian S Convery (RS)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Arabella Bouzigues (A)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Caroline V Greaves (CV)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Martina Bocchetta (M)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

David M Cash (DM)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

John C van Swieten (JC)

Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.

Lize Jiskoot (L)

Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands.

Fermin Moreno (F)

Cognitive Disorders Unit, Department of Neurology, Donostia Universitary Hospital, San Sebastian, Spain.
Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain.

Raquel Sanchez-Valle (R)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d'Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.

Robert Laforce (R)

Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, CHU de Québec, and Faculté de Médecine, Université Laval, Québec, Canada.

Caroline Graff (C)

Center for Alzheimer Research, Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Bioclinicum, Karolinska Institutet, Solna, Sweden.
Unit for Hereditary Dementias, Theme Aging, Karolinska University Hospital, Solna, Sweden.

Mario Masellis (M)

Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada.

Maria Carmela Tartaglia (MC)

Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.

James B Rowe (JB)

Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Barbara Borroni (B)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Elizabeth Finger (E)

Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada.

Matthis Synofzik (M)

Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany.
Center for Neurodegenerative Diseases (DZNE, Tübingen, Germany.

Daniela Galimberti (D)

Fondazione Ca' Granda, IRCCS Ospedale Policlinico, Milan, Italy.
University of Milan, Centro Dino Ferrari, Milan, Italy.

Rik Vandenberghe (R)

Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Neurology Service, University Hospitals Leuven, Leuven, Belgium.
Leuven Brain Institute, KU Leuven, Leuven, Belgium.

Alexandre de Mendonça (A)

Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

Chris R Butler (CR)

Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Department of Brain Sciences, Imperial College London, London, UK.

Alexander Gerhard (A)

Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, UK.
Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.

Simon Ducharme (S)

Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, QC, Canada.
McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.

Isabelle Le Ber (I)

Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Département de Neurologie, Centre de référence des démences rares ou précoces, IM2A, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Reference Network for Rare Neurological Diseases (ERN-RND), European Union.

Isabel Santana (I)

University Hospital of Coimbra (HUC), Neurology Service, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.

Florence Pasquier (F)

Univ Lille, Lille, France.
Inserm 1172, Lille, France.
CHU, CNR-MAJ, Labex Distalz, LiCEND Lille, Lille, France.

Johannes Levin (J)

Department of Neurology, Ludwig-Maximilians Universität München, Munich, Germany.
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.

Markus Otto (M)

Department of Neurology, University of Ulm, Ulm, Germany.

Sandro Sorbi (S)

Department of Neurofarba, University of Florence, Florence, Italy.
IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.

Jonathan D Rohrer (JD)

Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH